drugset / Trial / NCT07054398
Assessment of Serum Catestatin Level in Acne Vulgaris Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
Acne vulgaris is a persistent inflammatory condition of the pilosebaceous unit, affecting 85% of people between the ages of 12 and 24, it is regarded as one of the most common diseases in teenagers and young adults. Catestatin, a peptide derived from chromogranin A (CgA), was first discovered in 1997 as an acute nicotinic-cholinergic antagonist. Later, it was determined that CST is a pleiotropic hormone.
Timeline
- Start
- 2025-01-10
- Primary completion
- 2026-01-01
- Completion
- 2026-01-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Isotretinoin | Other / unclassified | — | Oral |